BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12698959)

  • 21. Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR.
    Rahman M; Ford CE; Cutler JA; Davis BR; Piller LB; Whelton PK; Wright JT; Barzilay JI; Brown CD; Colon PJ; Fine LJ; Grimm RH; Gupta AK; Baimbridge C; Haywood LJ; Henriquez MA; Ilamaythi E; Oparil S; Preston R;
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):989-1002. PubMed ID: 22490878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure?
    Proschan M; Ford CE; Cutler JA; Graumlich JF; Pavlik V; Cushman WC; Davis BR; Alderman MH; Gordon D; Furberg CD; Franklin SS; Blumenthal SS; Castaldo RS; Preston RA;
    Stat Med; 2013 Feb; 32(5):884-97. PubMed ID: 22961832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ALLHAT Trial. Diuretics are still the preferred initial drugs for high blood pressure.
    Vidt DG
    Cleve Clin J Med; 2003 Mar; 70(3):263-9. PubMed ID: 12678218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Cushman WC; Ford CE; Einhorn PT; Wright JT; Preston RA; Davis BR; Basile JN; Whelton PK; Weiss RJ; Bastien A; Courtney DL; Hamilton BP; Kirchner K; Louis GT; Retta TM; Vidt DG;
    J Clin Hypertens (Greenwich); 2008 Oct; 10(10):751-60. PubMed ID: 19090876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diuretics: older, cheaper, better.
    Johns Hopkins Med Lett Health After 50; 2003 Apr; 15(2):1-2. PubMed ID: 12712964
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Wright JT; Harris-Haywood S; Pressel S; Barzilay J; Baimbridge C; Bareis CJ; Basile JN; Black HR; Dart R; Gupta AK; Hamilton BP; Einhorn PT; Haywood LJ; Jafri SZ; Louis GT; Whelton PK; Scott CL; Simmons DL; Stanford C; Davis BR
    Arch Intern Med; 2008 Jan; 168(2):207-17. PubMed ID: 18227370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH
    Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Juraschek SP; Simpson LM; Davis BR; Shmerling RH; Beach JL; Ishak A; Mukamal KJ
    J Hypertens; 2020 May; 38(5):954-960. PubMed ID: 31977576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients.
    Wu SC; Liu CP; Chiang HT; Lin SL
    Heart Vessels; 2004 Jan; 19(1):13-8. PubMed ID: 14685749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Choice of antihypertensive agent in isolated systolic hypertension and isolated diastolic hypertension: A secondary analysis of the ALLHAT trial.
    Wang SY; Hanna JM; Gongal P; Onuma OK; Nanna MG
    Am Heart J; 2022 Dec; 254():30-34. PubMed ID: 35932912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A family physician questions the conclusions from ALLHAT.
    Standridge JB
    Am J Hypertens; 2004 Apr; 17(4):361-5. PubMed ID: 15062891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of chlorthalidone, amlodipine, and lisinopril as first-step treatment for patients with hypertension: an analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Heidenreich PA; Davis BR; Cutler JA; Furberg CD; Lairson DR; Shlipak MG; Pressel SL; Nwachuku C; Goldman L
    J Gen Intern Med; 2008 May; 23(5):509-16. PubMed ID: 18228109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ALLHAT in perspective: implications to clinical practice and clinical trials.
    Yusoff K
    Med J Malaysia; 2005 Jun; 60(2):239-45. PubMed ID: 16114170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initial choice of antihypertensive on long-term cardiovascular outcomes in CKD.
    Whaley-Connell A; Sowers JR
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):884-6. PubMed ID: 22595830
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevention of Heart Failure in Hypertension-Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study.
    Johnson K; Oparil S; Davis BR; Tereshchenko LG
    J Am Heart Assoc; 2019 Apr; 8(8):e011961. PubMed ID: 30943832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Amlodipine is the better partner].
    Einecke D
    MMW Fortschr Med; 2008 Apr; 150(16):13-4. PubMed ID: 18557108
    [No Abstract]   [Full Text] [Related]  

  • 37. The putative link between glycemic control and cardiac arrhythmias.
    Varughese GI; Tahrani AA; Scarpello JH
    Arch Intern Med; 2007 Jul; 167(13):1433-4; author reply 1434-5. PubMed ID: 17620539
    [No Abstract]   [Full Text] [Related]  

  • 38. Association of 3 Different Antihypertensive Medications With Hip and Pelvic Fracture Risk in Older Adults: Secondary Analysis of a Randomized Clinical Trial.
    Puttnam R; Davis BR; Pressel SL; Whelton PK; Cushman WC; Louis GT; Margolis KL; Oparil S; Williamson J; Ghosh A; Einhorn PT; Barzilay JI;
    JAMA Intern Med; 2017 Jan; 177(1):67-76. PubMed ID: 27893045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT.
    Piller LB; Simpson LM; Baraniuk S; Habib GB; Rahman M; Basile JN; Dart RA; Ellsworth AJ; Fendley H; Probstfield JL; Whelton PK; Davis BR;
    J Gen Intern Med; 2014 Nov; 29(11):1475-83. PubMed ID: 25002161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.
    Karotsis AK; Symeonidis A; Mastorantonakis SE; Stergiou GS;
    Clin Exp Hypertens; 2006 Oct; 28(7):655-62. PubMed ID: 17060064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.